← All Sponsors
SPONSOR

Juan P. Alderuccio, MD

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Follicular Lymphoma
NCT04998669 Phase 2
Recruiting

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Follicular Lymphoma
United States View Trial →